Plasma levels of soluble CD30, tumour necrosis factor (TNF)-α and TNF receptors during primary HIV-1 infection: Correlation with HIV-1 RNA and the clinical outcome

AIDS

Volumn 10, Issue 13, 1996, Pages

  Rizzardi, G Paolo ^a,e   Barcellini, Wilma ^a   Tambussi, Giuseppe ^b   Lillo, Flavia ^b   Malnati, Mauro ^c   Perrin, Luc ^d   Lazzarin, Adriano ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Unit of Human Virology   (Italy)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Acute HIV 1 infection; Cellular factors cytokines; Disease progression; HIV 1 RNA; Soluble CD30; Soluble TNF receptors; Tumour necrosis factor (TNF)

Indexed keywords

CD30 ANTIGEN; DIDANOSINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VIRUS RNA; ZIDOVUDINE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LYMPHOCYTE COUNT; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK; SEROCONVERSION; T LYMPHOCYTE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0029841022     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199611000-00001     Document Type: Article

References (18)

1. Graziosi C, Pantaleo G, Butini L, et al.: Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993, 90:6405-6409.
2. Pantaleo G, Demarest JF, Soudeyns H, et al.: Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994, 370:463-467.
3. Hirsch VM, Fuerst TR, Sutter G, et al.: Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol 1996, 70:3741-3752.
4. Barcellini W, Rizzardi GP, Poli G, et al.: Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection. AIDS Res Hum Retroviruses 1996, 12:325-331.
5. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170.
6. Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41:1-19.
7. Kinloch-de-Loës S, Hirschel BJ, Hoen B, et al.: A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995, 333:408-413.
8. Aukrust P, Liabakk N, Müller F, Lien E, Espevik T, Froland SS: Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection: correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994, 169:420-424.
9. Godfried MH, van der Poll T, Weverling GJ, et al.: Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 1994, 169:739-745.
10. Pizzolo G, Vinante F, Morosato L, et al.: High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 1994, 8:741-745.
11. Pantaleo G, Fauci AS: New concepts in the immunopathogenesis of HIV-infection. Annu Rev Immunol 1995, 13:487-512.
12. Mellors JW, Kingsley LA, Rinaldo CJ, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
13. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
14. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
15. Safrit JT, Koup RA: The immunology of primary HIV infection: which immune responses control HIV replication. Curr Opin Immunol 1995, 7:456-461.
16. Phillips AN: Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 1996, 271:497-499.
17. Pedersen C, Lindhardt BO, Jensen BL, et al.: Clinical course of primary HIV infection: consequences for subsequent course of infection. BMJ 1989, 299:154-157.
18. Ho D: Viral counts count in HIV infection. Science 1996, 272:1124-1125.